In a phase 3 randomized clinical trial, donanemab slowed clinical disease progression in amyloid-positive, early symptomatic Alzheimer’s patients over 76 weeks. The drug is currently under regulatory ...

The Office of Personnel Management (OPM) will again report on how much time and money federal employees spend on union activity after a hiatus during the Biden administration following a request from ...

The Office of Personnel Management (OPM) will again report on how much time and money federal employees spend on union activity after a hiatus during the Biden administration following a request ...

The life sciences industry experienced a dynamic year in 2024. As the public markets gained traction, IPO activity and venture investment saw a resurgence, signaling renewed investor confidence ...

Encourage children to love science by showing them the world in miniature with some of the best microscopes for kids — here are our favorite models. The best microscopes for kids allow children ...

If you’re looking for a future-proof 5G phone under ₹10,000 with a balance of performance and battery life, the Redmi 14C 5G is a worthy contender in this competitive segment. REDMI 14C 5G ...

Understanding how long a person can stay independent may help some people and clinicians determine if trying a drug such as lecanemab or donanemab is worth the risks and high prices. The study ...

President Donald Trump is putting mental health medications for kids under a new microscope. Some local parents are concerned about what the increased scrutiny could mean for their kids.

New research shows that lecanemab and donanemab can slow cognitive decline and extend patients' independence in daily activities. But with high costs and risks, are these treatments truly ...

The new season of Below Deck Down Under lost its first crew member before the second charter was even over. “We have to work together. You have some managing to do. It is your department ...